|
1
|
Libby P: Inflammation in atherosclerosis.
J Associat Physicians India. 48:265–266. 2012.
|
|
2
|
Ross R: Atherosclerosis-an inflammatory
disease. N Engl J Med. 340:115–126. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Banchereau J and Steinman RM: Dendritic
cells and the control of immunity. Nature. 392:245–252. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bobryshev YV and Watanabe T: Subset of
vascular dendritic cells transforming into foam cells in human
atherosclerotic lesions. Cardiovasc Pathol. 6:321–331. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chistiakov DA, Sobenin IA, Orekhov AN and
Bobryshev YV: Dendritic cells in atherosclerotic inflammation: The
complexity of functions and the peculiarities of pathophysiological
effects. Front Physiol. 5:1962014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Choi J, Do Y, Cheong C, Koh H, Boscardin
SB, Oh YS, Bozzacco L, Trumpfheller C, Park CG and Steinman RM:
Identification of antigen-presenting dendritic cells in mouse aorta
and cardiac valves. J Exp Med. 206:497–505. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Koltsova EK and Ley K: How dendritic cells
shape atherosclerosis. Trends Immunol. 32:540–547. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mellman I and Steinman RM: Dendritic
cells: Specialized and regulated antigen processing machines. Cell.
106:255–258. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen L: Co-inhibitory molecules of the
B7-CD28 family in the control of T-cell immunity. Nat Rev Immunol.
4:336–347. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Akira S and Takeda K: Toll-like receptor
signalling. Nat Rev Immunol. 4:499–511. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Son YI, Egawa S, Tatsumi T, Redlinger RE
Jr, Kalinski P and Kanto T: A novel bulk-culture method for
generating mature dendritic cells from mouse bone marrow cells. J
Immunol Methods. 262:145–157. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Paulson KE, Zhu SN, Chen M, Nurmohamed S,
Jongstra-Bilen J and Cybulsky MI: Resident intimal dendritic cells
accumulate lipid and contribute to the initiation of
atherosclerosis. Circ Res. 106:383–390. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Rong JX, Shapiro M, Trogan E and Fisher
EA: Transdifferentiation of mouse aortic smooth muscle cells to a
macrophage-like state after cholesterol loading. Proc Natl Acad Sci
USA. 100:13531–13536. 2003; View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ling GS, Bennett J, Woollard KJ, Szajna M,
Fossati-Jimack L, Taylor PR, Scott D, Franzoso G, Cook HT and Botto
M: Integrin CD11b positively regulates TLR4-induced signalling
pathways in dendritic cells but not in macrophages. Nat Commun.
5:30392014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chávez-Sánchez L, Espinosa-Luna JE,
Chávez-Rueda K, Legorreta-Haquet MV, Montoya-Díaz E and
Blanco-Favela F: Innate immune system cells in atherosclerosis.
Arch Med Res. 45:1–14. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Macritchie N, Grassia G, Sabir SR,
Maddaluno M, Welsh P, Sattar N, Ialenti A, Kurowska-Stolarska M,
McInnes IB, Brewer JM, et al: Plasmacytoid dendritic cells play a
key role in promoting atherosclerosis in apolipoprotein E-deficient
mice. Arterioscler Thromb Vasc Biol. 32:2569–2579. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Weeks MF, Rampersad RR and Liu P:
Dendritic cells and macrophages contribute differently to the
initiation of atherosclerosis. Circulation. 126:A157152012.
|
|
18
|
Hansson GK and Hermansson A: The immune
system in atherosclerosis. Nat Immunol. 12:204–212. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mempel TR, Henrickson SE and Von Andrian
UH: T-cell priming by dendritic cells in lymph nodes occurs in
three distinct phases. Nature. 427:154–159. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gautier EL, Huby T, Saint-Charles F,
Ouzilleau B, Pirault J, Deswaerte V, Ginhoux F, Miller ER, Witztum
JL, Chapman MJ and Lesnik P: Conventional dendritic cells at the
crossroads between immunity and cholesterol homeostasis in
atherosclerosis. Circulation. 119:2367–2375. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Glass CK and Witztum JL: Atherosclerosis:
The road ahead. Cell. 104:503–516. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hamada M, Nakamura M, Tran MT, Moriguchi
T, Hong C, Ohsumi T, Dinh TT, Kusakabe M, Hattori M, Katsumata T,
et al: MafB promotes atherosclerosis by inhibiting foam-cell
apoptosis. Nat Commun. 5:31472014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu SW, Qiao SB, Yuan JS and Liu DQ:
Association of plasma visfatin levels with inflammation,
atherosclerosis and acute coronary syndromes (ACS) in humans. Clin
Endocrinol (Oxf). 71:202–207. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
de Kleijn D and Pasterkamp G: Toll-like
receptors in cardiovascular diseases. Cardiovasc Res. 60:58–67.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hayashi C, Papadopoulos G, Gudino CV,
Weinberg EO, Barth KR, Madrigal AG, Chen Y, Ning H, LaValley M,
Gibson FC III, et al: Protective role for TLR4 signaling in
atherosclerosis progression as revealed by infection with a common
oral pathogen. J Immunol. 189:3681–3688. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Subramanian M, Thorp E, Hansson GK and
Tabas I: Treg-mediated suppression of atherosclerosis requires
MYD88 signaling in DCs. J Clin Invest. 123:179–188. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Alroqi FJ and Chatila TA: T regulatory
cell biology in health and disease. Curr Allergy Asthma Rep.
16:272016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sakaguchi S, Yamaguchi T, Nomura T and Ono
M: Regulatory T cells and immune tolerance. Cell. 133:775–787.
2008. View Article : Google Scholar : PubMed/NCBI
|
